JAC Advance Access originally published online on November 4, 2008
Journal of Antimicrobial Chemotherapy 2009 63(1):95-102; doi:10.1093/jac/dkn448
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original research |
Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium
1 Department of Nutrition and Food Science, University of Maryland, College Park, MD 20742, USA 2 Joint Institute for Food Safety and Applied Nutrition, University of Maryland, College Park, MD 20742, USA
Received 31 May 2008; returned 21 July 2008; revised 30 September 2008; accepted 2 October 2008
* Corresponding author. Tel: +1-301-405-1399; Fax: +1-301-314-3313; E-mail: jmeng{at}umd.edu
Objectives: Multidrug resistance (MDR) including fluoroquinolone resistance in Salmonella Typhimurium can result from overexpression of efflux pumps. We examined the mechanisms of fluoroquinolone resistance among in vitro-induced ciprofloxacin-resistant Salmonella Typhimurium mutants, LTL and LTH, derived from laboratory strain LT2.
Methods: Deletion mutation and RT–PCR techniques were employed to study the role of efflux pumps in fluoroquinolone resistance and their regulation cascades.
Results: In addition to point mutations in DNA gyrase (gyrA, gyrB) and topoisomerase IV (parC, parE) genes, increased expression of efflux pump genes, such as acrAB and acrEF, was observed in fluoroquinolone-resistant Salmonella strains. Constitutive expression of ramA containing a 9 bp deletion in the promoter region was directly associated with the overexpression of acrAB and acrEF and conferred an MDR phenotype in LTL. Inactivation of ramA increased the antimicrobial susceptibility of LTL, whereas complementation with the mutant allele induced an MDR phenotype in drug-susceptible Salmonella Typhimurium LT2, as demonstrated by 2- to 64-fold increases in resistance to fluoroquinolones, tetracycline and chloramphenicol. On the other hand, inactivation of mutant soxRS resulted in a slight increase in the susceptibility of LTH to several fluoroquinolone drugs, and the introduction of the mutant allele had no effect on antimicrobial susceptibility of LT2, indicating that constitutive expression of soxRS played a minimum role in fluoroquinolone resistance.
Conclusions: Mutations in the promoter region of ramA appear to play a role in the up-regulation of RamA and AcrAB, and RamA is an activator of the MDR regulation cascade in Salmonella Typhimurium.
Keywords: multidrug resistance , antimicrobial resistance , regulation
Present address: State Food and Drug Administration, Beijing, China
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Kehrenberg, A. Cloeckaert, G. Klein, and S. Schwarz Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of ramA and soxS J. Antimicrob. Chemother., December 1, 2009; 64(6): 1175 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Ricci and L. J. V. Piddock Only for substrate antibiotics are a functional AcrAB-TolC efflux pump and RamA required to select multidrug-resistant Salmonella Typhimurium J. Antimicrob. Chemother., September 1, 2009; 64(3): 654 - 657. [Full Text] [PDF]
|
|